Thomas Vollbrecht Selected Research

Therapeutics

11/2020	Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents.
7/2014	Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Vollbrecht Research Topics

Disease

4	Infections 11/2020 - 03/2010
2	Persistent Infection 11/2020 - 07/2014
2	Viremia 11/2020 - 07/2014
1	Hypersensitivity (Allergy) 01/2022
1	COVID-19 01/2022
1	Myocarditis (Carditis) 01/2022
1	HIV Infections (HIV Infection) 11/2020
1	Virus Diseases (Viral Diseases) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2011
1	Disease Progression 07/2010

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2022 - 07/2010
3	AntigensIBA 11/2020 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 07/2014
1	GadoliniumIBA 01/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Broadly Neutralizing AntibodiesIBA 11/2020
1	Histocompatibility Antigens Class IIBA 07/2014
1	EpitopesIBA 07/2014
1	Emtricitabine (Emtriva)FDA Link 09/2011
1	Tenofovir (Viread)FDA Link 09/2011
1	Chemokine CCL4IBA 07/2010
1	CytokinesIBA 03/2010

Therapy/Procedure

2	Therapeutics 11/2020 - 07/2014
1	Immunotherapy 07/2014